relationship between non-alcoholic fatty liver disease (NAFLD) (in particular, non-alcoholic steatohepatitis (NASH)) and diseases of the cardiovascular system (in particular, hypertonic disease) and to study the…
most common forms of chronic liver disease which may progress to non-alcoholic steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet…
compare a fuzzy numbers, some different ordering operators can be used. We define Nash equilibrium in fuzzy game using the ordering op erator. The game with crisp payoffs is associated ... statement: if the ordering…
prevalence of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is 25% or above worldwide. However, the safe and effective agents for NAFLD/NASH still require further investigation…
gauging stations of Great Ruaha River catchment. Performances of these methods were assessed using Nash-Sutcliffe efficiency, Root Mean Square Error and Mean Absolute Error. The results showed that, Multiple
constitute key factors in the pathogenesis of NAFLD and development of non-alcoholic steatohepatitis (NASH). Up to now, treatment of NAFLD is based on generalized dietary intervention. However, there
histology-confirmed steatoses obese and histology-confirmed advanced grade of NAFLD: Non-alcoholic steatohepatitis (NASH) obese patients were obtained during bariatric surgery. After randomized, eligible liver sample…
determined. Serum biomarkers were measured. Histopathological analysis was performed for microscopic non-alcoholic steatohepatitis (NASH) scoring. Marked acute hypophagia with 81.8, 75.3, 43.9, and 30.9% reductions in…
calibration and validation period. Obtained results are widely satisfactory with 0.74 as value of Nash coefficient. The swat model performance criteria show the ability of this model to reproduce faithfully
secure to jamming attacks and a jammer is derived and analyzed. More specifically, the Nash equilibrium is studied in terms of existence, individuality, and convergence under best reaction dynamics. Also
risk factors for NAFLD. Treating hypothyroidism can prevent the progression of NAFLD to NASH and subsequent CLD in obese. The observational cross sectional study was done in the Department ... which further increases…
availability of reliable non-alcoholic steatohepatitis (NASH) is crucial for the elucidation of its pathogenesis and evaluation of therapeutic candidates. The widely used high-fat high-Calorie (HFC) diet induces…
Based on the theory of Nash bargaining fairness concerns, the model is built in this paper. We explore that retailer confess or lie about its recycling cost, which impact
liver damage, ranging from simple steatosis to steatohepatitis and advanced fibrosis. Nonalcoholic steatohepatitis (NASH), a histological subtype of NAFLD characterized by hepatocyte injury and inflammation, is present…
assess the diagnostic value of serum markers of fibrosis and inflammation in patients with NASH. Patients & Methods: Serum concentrations of hyalurinic acid (HA), cytokeratine-18 fragments, TIMP1 and P3NP were…
also paves a new way to explain its mechanism of action. Non-alcoholic steatohepatitis (NASH) is considered the hepatic manifestation of metabolic syndrome. Fatty infiltration of the liver ... hallmark feature of…
also paves a new way to explain its mechanism of action. Non-alcoholic steatohepatitis (NASH) is considered the hepatic manifestation of metabolic syndrome. Fatty infiltration of the liver ... hallmark feature of…
nivolumab-(n=1) treatment with samples from normal liver (n=10), non-alcohol steatohepatitis (NASH, n=10), primary biliary cholangitis (PBC, n=10) or pembrolizumab-treated patients without adverse events ... patients…
induced obesity leads to an inflammatory and oxidative condition that promotes non-alcoholic steatohepatitis (NASH) development. We investigate the role of the hepatocyte HO-1-SIRT1 axis in attenuating steatohepatitis…
induced obesity leads to an inflammatory and oxidative condition that promotes non-alcoholic steatohepatitis (NASH) development. We investigate the role of the hepatocyte HO-1-SIRT1 axis in attenuating steatohepatitis…
Approximately 10–30% NAFLD have the potentially progressive form of Non-Alcoholic Steato-Hepatitis (NASH) and, approximately 25–40% of patients with NASH will develop progressive liver fibrosis, which ... with the…